Benjamin Rich Humpherys, DO | |
2121 N 1700 W, Layton, UT 84041-8803 | |
(801) 773-4840 | |
(801) 525-8702 |
Full Name | Benjamin Rich Humpherys |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 18 Years |
Location | 2121 N 1700 W, Layton, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891728036 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 4452 (Arizona) | Secondary |
2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | 6565196-1204 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Davis Hospital And Medical Center | Layton, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tanner Memorial Clinic | 4284547985 | 211 |
News Archive
Congressional Republicans said on Sunday they plan a full-scale assault against President Barack Obama's healthcare overhaul next year but acknowledged it could take until after the 2012 presidential election to repeal it. Representative Paul Ryan, expected to become chairman of the House Budget Committee chairman, said his fellow Republicans will try to deny funding for implementation of the healthcare legislation and hold hearings to point out its shortcomings when the new Congress convenes in January.
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate that remission in patients with rheumatoid arthritis is associated with an 80% reduction in risk of cardiovascular outcomes.
Acceleron Pharma, a biopharmaceutical company developing protein therapeutics for cancer and orphan disease, today announced that the Gynecologic Oncology Group (GOG) initiated a phase 2 study of dalantercept in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer.
The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen.
Stanford University professor Axel T. Brunger has been named the winner of the American Society for Biochemistry and Molecular Biology's inaugural DeLano Award for Computational Biosciences. Brunger will present his award lecture, titled "Towards Structural Biology with Single Molecules" at 9:03 a.m. on Wednesday, April 13, at the Experimental Biology 2011 conference at the Walter E. Washington Convention Center in Washington, D.C.
› Verified 8 days ago
Entity Name | Tanner Memorial Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447239355 PECOS PAC ID: 4284547985 Enrollment ID: O20031110000132 |
News Archive
Congressional Republicans said on Sunday they plan a full-scale assault against President Barack Obama's healthcare overhaul next year but acknowledged it could take until after the 2012 presidential election to repeal it. Representative Paul Ryan, expected to become chairman of the House Budget Committee chairman, said his fellow Republicans will try to deny funding for implementation of the healthcare legislation and hold hearings to point out its shortcomings when the new Congress convenes in January.
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate that remission in patients with rheumatoid arthritis is associated with an 80% reduction in risk of cardiovascular outcomes.
Acceleron Pharma, a biopharmaceutical company developing protein therapeutics for cancer and orphan disease, today announced that the Gynecologic Oncology Group (GOG) initiated a phase 2 study of dalantercept in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer.
The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen.
Stanford University professor Axel T. Brunger has been named the winner of the American Society for Biochemistry and Molecular Biology's inaugural DeLano Award for Computational Biosciences. Brunger will present his award lecture, titled "Towards Structural Biology with Single Molecules" at 9:03 a.m. on Wednesday, April 13, at the Experimental Biology 2011 conference at the Walter E. Washington Convention Center in Washington, D.C.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Benjamin Rich Humpherys, DO 2121 N 1700 W, Layton, UT 84041-8803 Ph: (801) 773-4840 | Benjamin Rich Humpherys, DO 2121 N 1700 W, Layton, UT 84041-8803 Ph: (801) 773-4840 |
News Archive
Congressional Republicans said on Sunday they plan a full-scale assault against President Barack Obama's healthcare overhaul next year but acknowledged it could take until after the 2012 presidential election to repeal it. Representative Paul Ryan, expected to become chairman of the House Budget Committee chairman, said his fellow Republicans will try to deny funding for implementation of the healthcare legislation and hold hearings to point out its shortcomings when the new Congress convenes in January.
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate that remission in patients with rheumatoid arthritis is associated with an 80% reduction in risk of cardiovascular outcomes.
Acceleron Pharma, a biopharmaceutical company developing protein therapeutics for cancer and orphan disease, today announced that the Gynecologic Oncology Group (GOG) initiated a phase 2 study of dalantercept in patients with persistent or recurrent ovarian, fallopian tube, or primary peritoneal cancer.
The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen.
Stanford University professor Axel T. Brunger has been named the winner of the American Society for Biochemistry and Molecular Biology's inaugural DeLano Award for Computational Biosciences. Brunger will present his award lecture, titled "Towards Structural Biology with Single Molecules" at 9:03 a.m. on Wednesday, April 13, at the Experimental Biology 2011 conference at the Walter E. Washington Convention Center in Washington, D.C.
› Verified 8 days ago
Brian H Morgan, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1916 N 700 W, Layton, UT 84041 Phone: 801-479-0312 Fax: 801-479-3364 | |
Mr. Gerald Wootton, MPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1203 N Fairfield Rd, Layton, UT 84041 Phone: 801-702-7718 Fax: 801-927-6236 | |
Douglas T Shepherd, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1916 Layton Hills Pkwy 250, Layton, UT 84041 Phone: 801-479-0312 Fax: 801-479-3364 | |
William F Brandt, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1916 Layton Hills Pkwy 250, Layton, UT 84041 Phone: 801-479-0312 Fax: 801-479-3364 |